HK1142888A1 - Macrolactone derivatives - Google Patents

Macrolactone derivatives

Info

Publication number
HK1142888A1
HK1142888A1 HK10109251.3A HK10109251A HK1142888A1 HK 1142888 A1 HK1142888 A1 HK 1142888A1 HK 10109251 A HK10109251 A HK 10109251A HK 1142888 A1 HK1142888 A1 HK 1142888A1
Authority
HK
Hong Kong
Prior art keywords
macrolactone
derivatives
macrolactone derivatives
Prior art date
Application number
HK10109251.3A
Other languages
English (en)
Inventor
Holger Hoffmann
Christine Klemke-Jahn
Dietmar Schummer
Herbert Kogler
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1142888A1 publication Critical patent/HK1142888A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK10109251.3A 2007-07-04 2010-09-28 Macrolactone derivatives HK1142888A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290841 2007-07-04
PCT/EP2008/004971 WO2009003595A2 (de) 2007-07-04 2008-06-20 Makrolakton-derivate

Publications (1)

Publication Number Publication Date
HK1142888A1 true HK1142888A1 (en) 2010-12-17

Family

ID=38508880

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10109251.3A HK1142888A1 (en) 2007-07-04 2010-09-28 Macrolactone derivatives

Country Status (23)

Country Link
US (1) US8268775B2 (pt)
EP (1) EP2173756B1 (pt)
JP (1) JP5539193B2 (pt)
KR (1) KR20100031716A (pt)
CN (1) CN101687884B (pt)
AR (1) AR071538A1 (pt)
AT (1) ATE502039T1 (pt)
AU (1) AU2008271631B2 (pt)
BR (1) BRPI0812827A2 (pt)
CA (1) CA2692260A1 (pt)
CL (1) CL2008001973A1 (pt)
DE (1) DE502008002892D1 (pt)
DK (1) DK2173756T3 (pt)
ES (1) ES2362814T3 (pt)
HK (1) HK1142888A1 (pt)
IL (1) IL202990A (pt)
MX (1) MX2009014204A (pt)
MY (1) MY146954A (pt)
PA (1) PA8787001A1 (pt)
PE (1) PE20090736A1 (pt)
PT (1) PT2173756E (pt)
UY (1) UY31204A1 (pt)
WO (1) WO2009003595A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010069850A1 (en) * 2008-12-17 2010-06-24 Sanofi-Aventis Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer
US11230553B2 (en) 2016-05-09 2022-01-25 The Research Foundation For The State University Of New York Nannocystin process and products
CN106083997B (zh) * 2016-07-05 2021-03-26 北京大学深圳研究生院 Nannocystin A及其结构类似物的合成
CN109280073A (zh) * 2017-07-19 2019-01-29 南开大学 Nannocystins衍生物及其用途
CN109796468B (zh) * 2019-03-26 2021-08-31 南开大学 大环nannocystin衍生物、及其制备方法和用途
CN114907367B (zh) * 2022-05-14 2024-06-14 福建省微生物研究所 大环内酯类化合物fw-z、其发酵菌株、发酵方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6233600A (en) * 1999-07-22 2001-02-13 Schering Aktiengesellschaft Process for the production of epothiolone b and derivatives as well as intermediate products for this process
AU2006226257A1 (en) * 2005-03-23 2006-09-28 Consejo Superior De Investigaciones Cientificas Polyene antibiotics, compositions containing said antibiotics, method and micro-organisms used to obtain same and applications thereof

Also Published As

Publication number Publication date
ES2362814T3 (es) 2011-07-13
WO2009003595A3 (de) 2009-04-09
AR071538A1 (es) 2010-06-30
IL202990A (en) 2013-10-31
PE20090736A1 (es) 2009-07-17
PT2173756E (pt) 2011-05-23
MY146954A (en) 2012-10-15
US8268775B2 (en) 2012-09-18
DK2173756T3 (da) 2011-07-18
MX2009014204A (es) 2010-01-28
WO2009003595A2 (de) 2009-01-08
CN101687884B (zh) 2012-10-31
KR20100031716A (ko) 2010-03-24
BRPI0812827A2 (pt) 2014-12-09
AU2008271631A1 (en) 2009-01-08
UY31204A1 (es) 2009-01-30
EP2173756B1 (de) 2011-03-16
CL2008001973A1 (es) 2008-11-03
CA2692260A1 (en) 2009-01-08
US20100256049A1 (en) 2010-10-07
JP5539193B2 (ja) 2014-07-02
PA8787001A1 (es) 2009-02-09
DE502008002892D1 (de) 2011-04-28
JP2010531823A (ja) 2010-09-30
AU2008271631B2 (en) 2013-06-06
ATE502039T1 (de) 2011-04-15
CN101687884A (zh) 2010-03-31
EP2173756A2 (de) 2010-04-14

Similar Documents

Publication Publication Date Title
HK1149756A1 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
EP2120569A4 (en) SPIROCHROMANONDERIVATE
IL202020A0 (en) Spiroindolinone derivatives
ZA201001058B (en) Quinazolinamide derivatives
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
ZA201000431B (en) Indazolamide derivatives
HK1134284A1 (en) Pyridizinone derivatives pyridizinone
IL193641A0 (en) Spiroindolinone derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
EP1973405A4 (en) HYDROXYALKYMARYLAMIDE DERIVATIVES
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL202667A0 (en) Isoxazole-imidazole derivatives
IL193211A0 (en) Indazole-heteroaryl derivatives
EP2141168A4 (en) HETEROARYLATED DERIVATIVES
PL2245028T3 (pl) Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2043633A4 (en) THIADIAZOLIDINONDERIVATE
EP2133347A4 (en) 1-BIARYLAZETIDINONDERIVATE
HK1142888A1 (en) Macrolactone derivatives
HK1141009A1 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
HK1146276A1 (en) Thiadiazinone derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170620